Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela A L, Tikanoja T, Paavilainen T, Simell O
Department of Pediatrics, Faculty of Medicine, University of Turku, Finland.
Am J Epidemiol. 1997 Sep 1;146(5):385-93. doi: 10.1093/oxfordjournals.aje.a009291.
Although idiopathic cardiomyopathies are prognostically important and are a common indication for cardiac transplantation in all age groups, the incidence and age distribution of idiopathic cardiomyopathies in a well-defined pediatric population have been poorly characterized. A retrospective study was carried out in Finland in 1980-1991 to obtain information on the epidemiology of childhood cardiomyopathies. The medical records of all patients aged birth to 20 years with cardiomyopathy from the five university hospitals and 16 central hospitals covering the entire country were reviewed. Moreover, data on causes of death from the Finnish National Census Bureau were examined. Of the 808 potential cases screened, 118 infants, children, and adolescents, representing an average age-specific population of 1.4 million, were definitely identified as having idiopathic cardiomyopathy. The average annual occurrence of new cases was 0.65 per 100,000 population (95% confidence interval (CI) 0.53-0.79). If the 15 cases diagnosed only after death during the 12-year study period were included, the occurrence increased to 0.74 per 100,000 population per year. Fifty-six new cases of dilated cardiomyopathy and 40 new cases of hypertrophic cardiomyopathy were diagnosed during the study period, giving average annual occurrences of 0.34/100,000/year (95% CI 0.26-0.44) and 0.24/100,000/year (95% CI 0.17-0.33) for new cases of dilated and hypertrophic cardiomyopathies, respectively. At the end of 1991, the prevalence of dilated cardiomyopathy was 2.6/100,000 (95% CI 1.8-3.6) and that for hypertrophic cardiomyopathy was 2.9/100,000 (95% CI 2.0-4.0). The number of new cases of dilated cardiomyopathy per year increased over the study period, whereas the annual occurrence of hypertrophic cardiomyopathy remained relatively constant. Marked variability was seen in occurrence among the different age groups of children with dilated cardiomyopathy, suggesting that different pathophysiologic mechanisms, and possibly etiologies, may exist in different age groups.
尽管特发性心肌病在预后方面很重要,且是所有年龄组心脏移植的常见指征,但在明确界定的儿科人群中,特发性心肌病的发病率和年龄分布情况一直未得到充分描述。1980年至1991年在芬兰进行了一项回顾性研究,以获取有关儿童心肌病流行病学的信息。对全国五所大学医院和16所中心医院中所有出生至20岁患有心肌病的患者的病历进行了审查。此外,还查阅了芬兰国家统计局的死亡原因数据。在筛查的808例潜在病例中,有118例婴儿、儿童和青少年被明确诊断为患有特发性心肌病,平均每140万特定年龄段人群中有1例。新病例的平均年发病率为每10万人0.65例(95%置信区间(CI)0.53 - 0.79)。如果将12年研究期间仅在死后才确诊的15例病例包括在内,发病率增至每年每10万人0.74例。在研究期间,诊断出56例扩张型心肌病新病例和40例肥厚型心肌病新病例,扩张型和肥厚型心肌病新病例的平均年发病率分别为0.34/10万/年(95% CI 0.26 - 0.44)和0.24/10万/年(95% CI 0.17 - 0.33)。到1991年底,扩张型心肌病的患病率为2.6/10万(95% CI 1.8 - 3.6),肥厚型心肌病的患病率为2.9/10万(95% CI 2.0 - 4.0)。在研究期间,每年扩张型心肌病新病例数有所增加,而肥厚型心肌病的年发病率相对保持稳定。在患有扩张型心肌病的不同年龄组儿童中,发病率存在明显差异,这表明不同年龄组可能存在不同的病理生理机制,甚至病因。